AlphAIalphai — Financial news for AI agents
TradingViewMAY 23 min read$RLAY

Relay Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Relay Therapeutics Inc is expected to report an earnings loss of 38 cents per share, according to a preview from Refinitiv. The article provides this key financial expectation for the company.

Original reporting
TradingView · Refinitiv
Published May 2, 2026, 3:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 2, 2026, 4:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$RLAY
Bearish
high confidence
Mentioned
$RLAY · $RLAY
alphai data visualization · based on TradingView
Decision brief

The 30-second read

$RLAYBearishMed
01

Why it matters

The anticipated loss reflects challenges in the company's pipeline or market conditions, which may influence investor confidence.

02

Market read

The upcoming earnings report is a critical event that could significantly influence the company's stock price and sector sentiment.

03

What to watch

Potential for sector-wide rally if biotech sector as a whole performs well; macroeconomic factors could also influence stock movement.

Timing: Immediate, as earnings are scheduled soon.

Background

Relay Therapeutics Inc operates in the biotech sector, focusing on precision medicines. The company is approaching a key earnings report that is expected to show a loss.

Company-level read

Ticker impact

$RLAYBearishHigh confidence
Context

The news pertains directly to Relay Therapeutics Inc, which is expected to report a significant earnings loss.

Expected impact

Potential decline in stock price in the short term, possibly 5-10% based on historical reactions to earnings misses.

Evidence & confidence

The earnings preview is based on reputable sources (Refinitiv) and reflects a concrete financial expectation, which historically influences stock movement.

$RLAYBearishHigh confidence
Context

The news is highly relevant as it directly concerns the company's upcoming earnings report.

Expected impact

Short-term downward pressure expected, with possible rebound if the company provides positive guidance post-earnings.

Evidence & confidence

Earnings reports are primary catalysts for stock movement; a significant expected loss typically results in bearish price action.

Market effects

Sector

The life sciences sector may experience increased volatility; biotech stocks with similar profiles could be affected.

Regional

Potential negative impact on regional biotech indices, especially if Relay is a significant component.

Global

Limited, as the impact is primarily sector-specific and company-specific.

Counterpoint

What could challenge this read

If Relay provides positive guidance or surprises on cost management, the stock could rebound, offering a buying opportunity.

Key entities

  • Company
    Relay Therapeutics Inc

    A biotech firm specializing in precision medicines.

Read at source← All news

Related articles

AUG 6
$RLAYMed

Relay Therapeutics, Inc. (RLAY): Results of Operations and Financial Condition

Relay Therapeutics, Inc. (RLAY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 4 rlay-ex99_2.htm EX-99.2 EX-99.2 Exhibit 99.2 Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates Selected zovegalisib plus atirmociclib as go-forward triplet regimen for 1L breast cancer; Phase 3 1L trial in endocrine-sensitive patient

SEC EDGAR 8-K6 min
JUN 2
$RLAYLowAI 8/10

Relay Therapeutics Shares Jump 18%

Relay Therapeutics’ shares (RLAY) rose 18.21% to $16.86 on Tuesday, up $2.60 from the prior close of $14.26 on the Nasdaq, despite no company-specific news. The stock traded between $16.04 and $17.47 and volume increased to 4,545,643 shares versus a 3,532,352 daily average. The 52-week range is $2.98–$17.47.

rttnews.com1 min
AUG 8
$BKRMed

Baker Hughes extends long-term service deal for Nigeria LNG Train 7

Baker Hughes said it won a 13-year lifecycle services deal with Nigeria LNG for turbomachinery at NLNG’s Train 7 expansion on Bonny Island. The scope covers heavy-duty gas turbines, centrifugal compressors, remote monitoring via Baker Hughes’ digital platform, and local support. Train 7 is expected to raise capacity from 22 to 30 MMtpa.

worldoil.com3 min
AUG 8
$BKRMed

Baker Hughes wins subsea systems contract for Angola's Greater PAJ field

Baker Hughes said it won a contract from Azule Energy to supply subsea production systems for the Greater PAJ ultra-deepwater project offshore Angola. Scope includes horizontal subsea trees, control modules, workover control systems and related equipment plus installation and support. Greater PAJ is expected to start producing in 2029 via an FPSO processing up to 95,000 bpd, with deliveries starting in 2027.

worldoil.com4 min
AUG 8
$WENMed

57-year-old Burger chain closed 28 restaurants, 100s more coming

Wendy’s (WEN) said it closed 28 restaurants and expects to close 5% to 6% of U.S. units (about 289 to 358) in 1H 2026, with possible additional selective closures. The company reported 2Q FY2026 systemwide sales down 6.5% YoY, U.S. systemwide down 8.2%, and U.S. same-restaurant sales down 7%. Wendy’s launched a turnaround plan and withdrew its 2026 outlook.

yahoo.com6 min